GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)
GUIDE:一项随机、非对照 II 期试验,比较生物标志物驱动的间歇性多西他赛与标准治疗多西他赛在转移性去势抵抗性前列腺癌中的疗效(临床试验方案)
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359221092486
Conduit, Ciara; Mak, Blossom; Qu, Wenjia; Lulio, Juliana Di; Burder, Ronan; Bressel, Matthias; Cusick, Thomas; Dhillon, Haryana M; Lourenço, Richard De Abreu; Underhill, Craig; Torres, Javier; Crumbaker, Megan; Honeyball, Florian; Linton, Anthony; Allen, Ray; Davis, Ian D; Clark, Susan J; Horvath, Lisa G; Mahon, Kate L